64 related articles for article (PubMed ID: 11400952)
1. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Cao TM; Horning S; Negrin RS; Hu WW; Johnston LJ; Taylor TL; Shizuru JA; Hoppe RT; Brown BW; Blume KG; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 2001; 7(5):294-301. PubMed ID: 11400952
[TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.
Kothari J; Peggs KS; Bird A; Thomson KJ; Morris E; Virchis AE; Lambert J; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2014 May; 165(3):334-40. PubMed ID: 24438080
[TBL] [Abstract][Full Text] [Related]
3. [IEAC versus CEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for lymphoma: analysis of efficacy and safety in 106 cases].
Xiong Y; Chen J; Liu L; Luo X; Tang X; Wang X; Xiao Q; Zhang H; Wang L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1760-1767. PubMed ID: 33380399
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
Lane AA; Armand P; Feng Y; Neuberg DS; Abramson JS; Brown JR; Fisher DC; LaCasce AS; Jacobsen ED; McAfee SL; Spitzer TR; Freedman AS; Chen YB
Leuk Lymphoma; 2012 Jun; 53(6):1130-6. PubMed ID: 22132836
[TBL] [Abstract][Full Text] [Related]
5. Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation.
Eyre TA; Barrington SF; Okosun J; Abamba C; Pearce RM; Lee J; Carpenter B; Crawley CR; Bloor AJC; Gilleece M; Nicholson E; Shah N; Orchard K; Malladi R; Townsend WM
Haematologica; 2023 Mar; 108(3):785-796. PubMed ID: 35586966
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Wirk B; Fenske TS; Hamadani M; Zhang MJ; Hu ZH; Akpek G; Aljurf MD; Armand P; Ayala E; Bachanova V; Bolwell B; Cairo MS; Cashen A; Chen YB; Costa LJ; Farhan S; Freytes CO; Gajewski JL; Gibson J; Hale GA; Holmberg LA; Hsu JW; Inwards DJ; Kamble RT; Maharaj D; Maziarz RT; Munker R; Nath R; Reddy NM; Reeder CB; Rizzieri DA; Sauter CS; Savani BN; Schouten HC; Sureda A; Vose JM; Waller EK; Wiernik PH; Gale RP; Burns LJ; Saber W
Biol Blood Marrow Transplant; 2014 Jul; 20(7):951-9. PubMed ID: 24641828
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients.
Jeon Y; Kim TY; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Cytotherapy; 2023 Dec; 25(12):1307-1316. PubMed ID: 37542512
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis.
Malogolowkin MH; Hemmer MT; Le-Rademacher J; Hale GA; Mehta PA; Smith AR; Kitko C; Abraham A; Abdel-Azim H; Dandoy C; Angel Diaz M; Gale RP; Guilcher G; Hayashi R; Jodele S; Kasow KA; MacMillian ML; Thakar M; Wirk BM; Woolfrey A; Thiel EL
Bone Marrow Transplant; 2017 Nov; 52(11):1549-1555. PubMed ID: 28869618
[TBL] [Abstract][Full Text] [Related]
9. Transformed lymphoma: what should I do now?
Smith S
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):306-311. PubMed ID: 33275671
[TBL] [Abstract][Full Text] [Related]
10. Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Casulo C; Friedberg JW; Ahn KW; Flowers C; DiGilio A; Smith SM; Ahmed S; Inwards D; Aljurf M; Chen AI; Choe H; Cohen J; Copelan E; Farooq U; Fenske TS; Freytes C; Gaballa S; Ganguly S; Jethava Y; Kamble RT; Kenkre VP; Lazarus H; Lazaryan A; Olsson RF; Rezvani AR; Rizzieri D; Seo S; Shah GL; Shah N; Solh M; Sureda A; William B; Cumpston A; Zelenetz AD; Link BK; Hamadani M
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1163-1171. PubMed ID: 29242111
[TBL] [Abstract][Full Text] [Related]
11. Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma.
Kenyeres A; Kiss E; Simon Z; Illés Á; Jóna Á
J Int Med Res; 2024 Feb; 52(2):3000605231221012. PubMed ID: 38321883
[TBL] [Abstract][Full Text] [Related]
12. Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomas.
Nath SV; Prince HM; Choong PF; Toner GC
Int Semin Surg Oncol; 2005 May; 2(1):12. PubMed ID: 15927067
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of dose-intensified salvage regimens versus standard-dose chemotherapy on progression-free survival in early progressed follicular lymphoma before autologous stem cell transplantation: a systematic review protocol.
Pereira Mesquita F; Borges Dos Santos K; Takahashi JA; Guimarães Dutra Giffoni Dos Santos M; Felizardo Alvim G; Hallack Neto AE
JBI Evid Synth; 2024 May; ():. PubMed ID: 38727146
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma.
Djebbari F; Kaji F; Stanton L; Lawrence MM; Collins GP; Eyre TA
Eur J Haematol; 2020 Nov; 105(5):667-671. PubMed ID: 32668063
[No Abstract] [Full Text] [Related]
15. Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data.
Rajamäki A; Hujo M; Sund R; Prusila REI; Kuusisto MEL; Kuitunen H; Jantunen E; Mercadal S; Sorigue M; Sancho JM; Sunela K; Kuittinen O
JCO Clin Cancer Inform; 2023 Sep; 7():e2300067. PubMed ID: 37756639
[TBL] [Abstract][Full Text] [Related]
16. Beyond remission: secondary primary malignancies in patients with lymphoma after autologous haematopoietic stem-cell transplantation.
Sureda A; Domingo-Domenech E
Lancet Haematol; 2023 Oct; 10(10):e790-e791. PubMed ID: 37689082
[No Abstract] [Full Text] [Related]
17. Diagnosis of follicular lymphoma from the peripheral blood.
Bain BJ
Am J Hematol; 2018 Jun; ():. PubMed ID: 29885001
[No Abstract] [Full Text] [Related]
18. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.
Jiménez-Ubieto A; Grande C; Caballero D; Yáñez L; Novelli S; Hernández-Garcia MT; Manzanares M; Arranz R; Ferreiro JJ; Bobillo S; Mercadal S; Galeo A; Jiménez JL; Moraleda JM; Vallejo C; Albo C; Pérez E; Marrero C; Magnano L; Palomera L; Jarque I; Rodriguez A; Lorza L; Martín A; Coria E; López-Guillermo A; Salar A; José Lahuerta J;
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):194-203. PubMed ID: 31319058
[TBL] [Abstract][Full Text] [Related]
19. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716
[TBL] [Abstract][Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.
Helbig G; Krawczyk-Kulis M; Kopinska A; Liwoch R; Kyrcz-Krzemien S
Med Oncol; 2014 Dec; 31(12):310. PubMed ID: 25373321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
